Dihydropteridinones for the treatment of cancer diseases

Details for Australian Patent Application No. 2005274387 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Steegmaier, Martin; Munzert, Gerd

Agent Davies Collison Cave

Pub. Number AU-B-2005274387

PCT Pub. Number WO2006/018185

Priority 04019359.1 14.08.04 EP

Filing date 9 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 17 March 2011

International Classifications

A61K 31/525 (2006.01)

A61K 31/5377 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/018185 Priority application(s): WO2006/018185

17 March 2011 Application Accepted

  Published as AU-B-2005274387

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274390-Substituted hydantoins

2005274384-Combinations for the treatment of diseases involving cell proliferation